CVS Health Co. (NYSE:CVS) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of CVS Health Co. (NYSE:CVSGet Rating) have been assigned an average rating of “Moderate Buy” from the twenty-three ratings firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, sixteen have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $116.05.

Several equities research analysts have issued reports on CVS shares. Loop Capital began coverage on shares of CVS Health in a research note on Thursday, June 16th. They set a “buy” rating and a $120.00 price objective for the company. Deutsche Bank Aktiengesellschaft increased their target price on shares of CVS Health from $110.00 to $113.00 in a research report on Thursday, May 5th. Sanford C. Bernstein cut shares of CVS Health from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $122.00 to $112.00 in a research report on Thursday, May 26th. Finally, Tigress Financial upped their price objective on shares of CVS Health from $122.00 to $125.00 in a report on Thursday, April 7th.

CVS Health Trading Down 0.7 %

Shares of CVS Health stock opened at $95.37 on Wednesday. The company has a market capitalization of $125.06 billion, a P/E ratio of 15.84, a PEG ratio of 1.50 and a beta of 0.75. The company’s fifty day moving average is $94.11 and its two-hundred day moving average is $99.97. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.62 and a current ratio of 0.88. CVS Health has a 1 year low of $79.33 and a 1 year high of $111.25.

CVS Health (NYSE:CVSGet Rating) last posted its quarterly earnings data on Wednesday, May 4th. The pharmacy operator reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.08. CVS Health had a net margin of 2.67% and a return on equity of 15.33%. The business had revenue of $76.83 billion during the quarter, compared to analyst estimates of $75.30 billion. During the same quarter in the previous year, the business posted $2.04 earnings per share. The company’s revenue was up 11.2% on a year-over-year basis. Analysts forecast that CVS Health will post 8.34 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Shareholders of record on Friday, July 22nd were paid a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date was Thursday, July 21st. CVS Health’s dividend payout ratio (DPR) is currently 36.54%.

Insider Activity at CVS Health

In other news, EVP Thomas M. Moriarty sold 138,654 shares of the company’s stock in a transaction dated Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the completion of the transaction, the executive vice president now directly owns 626,273 shares of the company’s stock, valued at approximately $59,495,935. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.69% of the company’s stock.

Institutional Investors Weigh In On CVS Health

Hedge funds have recently made changes to their positions in the business. Revolve Wealth Partners LLC lifted its stake in shares of CVS Health by 2.8% during the first quarter. Revolve Wealth Partners LLC now owns 4,328 shares of the pharmacy operator’s stock worth $438,000 after purchasing an additional 119 shares in the last quarter. Acropolis Investment Management LLC grew its holdings in shares of CVS Health by 77.1% during the first quarter. Acropolis Investment Management LLC now owns 3,018 shares of the pharmacy operator’s stock valued at $305,000 after purchasing an additional 1,314 shares during the last quarter. Glassy Mountain Advisors Inc. grew its holdings in CVS Health by 1.1% in the 1st quarter. Glassy Mountain Advisors Inc. now owns 72,680 shares of the pharmacy operator’s stock worth $7,356,000 after buying an additional 825 shares in the last quarter. DeDora Capital Inc. acquired a new stake in CVS Health in the first quarter worth approximately $68,000. Finally, Dowling & Yahnke LLC lifted its position in shares of CVS Health by 2.9% during the 1st quarter. Dowling & Yahnke LLC now owns 66,534 shares of the pharmacy operator’s stock valued at $6,734,000 after acquiring an additional 1,858 shares during the last quarter. Institutional investors and hedge funds own 78.00% of the company’s stock.

CVS Health Company Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Read More

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.